CDKN2A and cancer: This is possibly because the ARF gene is inactivated in human cancer by gene deletion, splicing alteration than INK4a, which is inactivated mainly by promoter methylation or coding exon point mutations [5,16]; for splicing errors for ARF, see ref. [2]).